Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.040 | 1.000 | 4 | 2014 | 2019 | ||||||
Malignant neoplasm of breast
|
3417 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.040 | 1.000 | 4 | 2014 | 2019 | ||||||
Multiple Sclerosis
|
1022 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.040 | 1.000 | 4 | 2015 | 2019 | ||||||
Allergic rhinitis (disorder)
|
176 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.030 | 0.667 | 3 | 2011 | 2017 | ||||||
Acute Chest Syndrome
|
135 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2013 | 2016 | ||||||
Autoimmune Diseases
|
428 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||
Graves Disease
|
352 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2013 | 2019 | ||||||
Malignant Neoplasms
|
1641 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Neoplasms
|
1644 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||||
Primary malignant neoplasm
|
1374 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
Tumor Progression
|
72 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||||
Vitiligo
|
249 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
92 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||
Autism Spectrum Disorders
|
331 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Autoimmune thyroid disease (AITD)
|
54 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1 | 2019 | 2019 | |||||||
Chronic kidney disease stage 5
|
194 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Colorectal Carcinoma
|
1962 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Crohn Disease
|
1147 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Cytomegalovirus Infections
|
26 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Degenerative polyarthritis
|
247 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Endometrial Carcinoma
|
326 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Endometriosis
|
274 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Graft-vs-Host Disease
|
25 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1 | 2016 | 2016 | |||||||
Hashimoto Disease
|
131 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
24 | 0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 |